Recipient of federal assistance · CAMBRIDGE, MA

QUIVER BIOSCIENCE INC.

QUIVER BIOSCIENCE INC. received $2.9M in federal grants and other assistance in FY2026, on 5 actions, +215% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $13.6M. Its largest awarding agency was National Institutes of Health ($2.9M).

Assistance · FY2026
$2.9M
New awards
1
Actions
5
Since FY2021
$13.6M
UEI
L9HHRYCBMBZ1
Location
CAMBRIDGE, MA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.7MFY2021
  2. 995.3KFY2022
  3. 4.4MFY2023
  4. 2.8MFY2024
  5. 913.9KFY2025
  6. 2.9MFY2026

By type

  1. Grants$2.9M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.279 · Drug Use and Addiction Research Programs$2M69%
  2. 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders$886K31%

Awarding agencies

  1. National Institutes of Health$2.9M100%
    Department of Health and Human Services

Largest awards

  1. BRITE-EYE: AN INTEGRATED DISCOVERY ENGINE FOR CNS THERAPEUTIC TARGETS DRIVEN BY HIGH THROUGHPUT GENETIC SCREENS, FUNCTIONAL READOUTS IN…$3M
    93.242 · Mental Health Research Grants· National Institutes of Health· Project grant· Sep 19, 2023 – Dec 17, 2025· R44MH135521
  2. ULTRA-HIGH-THROUGHPUT PLATE READER FOR DRUG DISCOVERY USING ALL-OPTICAL ELECTROPHYSIOLOGY - PROJECT SUMMARY: ULTRA-HIGH-THROUGHPUT PLATE…$3M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Sep 13, 2022 – Apr 30, 2026· R44NS125689
  3. FUNCTIONAL DRUG FINGERPRINTING WITH ALL-OPTICAL ELECTROPHYSIOLOGY - PROJECT SUMMARY PHASE II: FUNCTIONAL DRUG FINGERPRINTING WITH…$2.5M
    93.242 · Mental Health Research Grants· National Institutes of Health· Project grant· Jul 19, 2022 – Dec 17, 2025· R44MH122052
  4. DEVELOPMENT OF NAV CHANNEL TARGETING ANTISENSE OLIGONUCLEOTIDES AS CHRONIC PAIN THERAPEUTICS USING AN INTEGRATED PLATFORM BASED ON MACHINE…$2M
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Cooperative agreement· Apr 28, 2026 – Apr 28, 2026· UG3NS146009
  5. SAFE-OPTION: OPTICAL PHYSIOLOGY TO INTERROGATE OLIGONUCLEOTIDE NEUROTOXICITY - PROJECT SUMMARY: SAFE-OPTION: OPTICAL PHYSIOLOGY TO…$1.7M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· May 20, 2025 – May 5, 2026· R44NS141534

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2021–FY2026.